×
About 13,668 results

ALLMedicine™ Erectile Dysfunction Center

Research & Reviews  3,835 results

Understanding and treating ejaculatory dysfunction in men with Diabetes mellitus.
https://doi.org/10.1111/andr.13262
Andrology Desai A, Chen R et. al.

Aug 8th, 2022 - Diabetes mellitus (DM) is a rapidly rising metabolic disorder with important systemic complications. Global figures have demonstrated the prevalence of DM has almost quadrupled from 108 million in 1980 to 422 million in 2014, with a current preval...

Functional characteristics and research trends of PDE11A in human diseases (Review).
https://doi.org/10.3892/mmr.2022.12814
Molecular Medicine Reports; Kong G, Lee H et. al.

Aug 6th, 2022 - cAMP and cGMP are important secondary messengers involved in cell regulation and metabolism driven by the G protein‑coupled receptor. cAMP is converted via adenylyl cyclase (AC) and activates protein kinase A to phosphorylate intracellular protein...

Relationships of low-grade systemic inflammation and nutritional status with erectile d...
https://doi.org/10.1111/andr.13259
Andrology Fujita N, Hatakeyama S et. al.

Aug 6th, 2022 - Low-grade systemic inflammation and malnutrition are frequently observed in patients on dialysis and contribute to the development of endothelial dysfunction, however, the role of these conditions in erectile dysfunction (ED) severity remains to b...

The management of erectile dysfunction in men with diabetes mellitus unresponsive to Ph...
https://doi.org/10.1111/andr.13257
Andrology Cayetano-Alcaraz AA, Tharakan T et. al.

Aug 6th, 2022 - Erectile dysfunction (ED) is associated with diabetes mellitus with an estimated prevalence of 52.5% in the diabetic population. The first-line therapy for ED are phosphodiesterase type 5 inhibitors (PDE5i), but data suggests that diabetic men may...

Scrutinizing the Therapeutic Promise of Purinergic Receptors Targeting Depression.
https://doi.org/10.1007/s12640-022-00550-2
Neurotoxicity Research; Sikka P, Behl T et. al.

Aug 6th, 2022 - Antidepressant use has resulted in a variety of negative consequences, including permanent brain damage and erectile dysfunction. So, the purpose lies in developing something more productive with minimal side effects and consequently improved effi...

see more →

Guidelines  13 results

Acute Ischemic Priapism: An AUA/SMSNA Guideline.
https://doi.org/10.1097/JU.0000000000002236
The Journal of Urology; Bivalacqua TJ, Allen BK et. al.

Sep 9th, 2021 - Priapism is a persistent penile erection that continues hours beyond, or is unrelated to, sexual stimulation and results in a prolonged and uncontrolled erection. Given its time-dependent and progressive nature, priapism is a situation that both u...

My Treatment Approach to Multiple System Atrophy.
https://doi.org/10.1016/j.mayocp.2020.10.005
Mayo Clinic Proceedings; Coon EA, Ahlskog JE

Mar 7th, 2021 - Multiple system atrophy (MSA) is a neurodegenerative disorder primarily characterized by autonomic failure plus parkinsonism or cerebellar ataxia. The diagnosis may be challenging and is usually made at a tertiary care center. The long-term manage...

Erectile Dysfunction: AUA Guideline.
https://doi.org/10.1016/j.juro.2018.05.004
The Journal of Urology; Burnett AL, Nehra A et. al.

May 11th, 2018 - The purpose of this guideline is to provide a clinical strategy for the diagnosis and treatment of erectile dysfunction. A systematic review of the literature using the Pubmed, Embase, and Cochrane databases (search dates 1/1/1965 to 7/29/17) was ...

British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunctio...
https://doi.org/10.1016/j.jsxm.2018.01.023
The Journal of Sexual Medicine; Hackett G, Kirby M et. al.

Mar 20th, 2018 - This is an update of the 2008 British Society for Sexual Medicine (BSSM) guidelines. To provide up-to-date guidance for U.K. (and international) health care professionals managing male sexual dysfunction. Source information was obtained from peer-...

Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From ...
https://doi.org/10.1016/j.jsxm.2016.11.324
The Journal of Sexual Medicine; Salonia A, Adaikan G et. al.

Mar 7th, 2017 - Sexual dysfunction is common in patients after radical prostatectomy (RP) for prostate cancer. To provide the International Consultation for Sexual Medicine (ICSM) 2015 recommendations concerning management strategies for post-RP erectile function...

see more →

Drugs  313 results see all →

Clinicaltrials.gov  557 results

Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT04808427

Aug 5th, 2022 - Background: Prostate cancer is relatively slow growing, with doubling times for local tumors estimated at 2 to 4 years. Some prostate cancers prove to be small, low grade, and noninvasive and they appear to pose little risk to the life or health o...

Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical Prostatectomy
https://clinicaltrials.gov/ct2/show/NCT05266313

Aug 5th, 2022 - 80% of patients undergoing radical prostatectomy report urinary incontinence and erectile dysfunction [Johanssen et al. 2011. Scandinavian Prostate Cancer Group Study]. In the West Indies, the incidence of prostate cancer is one of the highest in ...

Quality of Life in Prostate Cancer Patients
https://clinicaltrials.gov/ct2/show/NCT04357925

Aug 4th, 2022 - The Martinique Cancer Registry database is the largest clinical database among the French population-based cancer registries in the Caribbean, including more than 38 000 cancer cases, with 1650 new cancer cases per year, including 550 new PCa case...

Investigational and Comparative Study in the Management of Diabetic Nephropathy
https://clinicaltrials.gov/ct2/show/NCT05487755

Aug 4th, 2022 - Diabetic nephropathy(DN) is one of the major micro- vascular complications of diabetes mellitus and the leading cause of end-stage renal disease (ESRD) that require renal replacement therapies. The average incidence of diabetic nephropathy is 3% p...

Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients
https://clinicaltrials.gov/ct2/show/NCT04686916

Aug 3rd, 2022 - This is a Phase IIa, randomised, double-blind, placebo-controlled, 3-period, crossover study to assess two single oral dose levels of IP2018. It is planned to enrol 24 patients. Patients will take part in three treatment periods, in which they wil...

see more →

News  718 results

For Men, Peyronie's a Touchy Topic — But Help Is Available
https://www.medscape.com/viewarticle/978206

Jul 28th, 2022 - Dennis Wallace's journey through his treatment of a little-discussed male disorder started 5 years ago with a "Hmm" moment, followed by little discussion. "I just started to notice a bend in my penis when it was erect," says Wallace. He showed his...

52-year-old man • erectile dysfunction • insomnia • migraine headaches • disclosure of infidelity
https://www.mdedge.com/familymedicine/article/256322/mens-health
MDedge Family Medicine; Matthew Alexander, PhD, David C. Slawson, MD

Jul 18th, 2022 - THE CASE A 52-year-old man requested medicine to help him with erectile dysfunction. After obtaining a medical history and performing a physical exam, the family physician (FP) asked for more details about the patient’s situation.

SARS-CoV-2: A Novel Precipitant of Ischemic Priapism
https://www.mdedge.com/fedprac/article/256292/covid-19-updates/sars-cov-2-novel-precipitant-ischemic-priapism
Lorraine Mascarenhas, MD, Danielle Hron, MD et. al.

Jul 15th, 2022 - Priapism is a disorder that occurs when the penis maintains a prolonged erection in the absence of appropriate stimulation. The disorder is typically divided into subgroups based on arterial flow: low flow (ischemic) and high flow (nonischemic).

When to Treat Low Testosterone in Diabetes and Obesity
https://www.medscape.com/viewarticle/977284

Jul 15th, 2022 - Men with type 2 diabetes are at higher risk for testosterone deficiency. And in turn, hypogonadism is commonly associated with metabolic syndrome or type 2 diabetes. However, this does not imply a specific need for action, as Stephan Petersenn, MD...

Misoprostol: Clinical pharmacology in obstetrics and gynecology
https://www.mdedge.com/obgyn/article/256249/obstetrics/misoprostol-clinical-pharmacology-obstetrics-and-gynecology
Robert L. Barbieri, MD

Jul 13th, 2022 - Oxytocin and prostaglandins are critically important regulators of uterine contraction. Obstetrician-gynecologists commonly prescribe oxytocin and prostaglandin agonists (misoprostol, dinoprostone) to stimulate uterine contraction for the inductio.

see more →

Patient Education  31 results see all →